At the time of reporting the CMT1A duplication/HNPP deletion, this represented a seminal discovery for structural variation (CNV) causing IPN and demonstrated the sensitivity of nervous tissue to gene dosage changes due to the gain or loss of a copy of the PMP22 gene. Here, PMP22 is linked to bile duct papillary neoplasm.